PHR · Phreesia, Inc.
Market Cap
$679.06M
Shares
62.07M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $8,077,706 |
| Evan Roberts | President, Provider Solutions | $3,658,873 |
| Balaji Gandhi | Chief Financial Officer | $3,658,873 |
| David Linetsky | President, Network Solutions | $3,627,217 |
| Allison Hoffman | General Counsel | $2,645,335 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $10,511,050 |
| Balaji Gandhi | Chief Financial Officer | $4,519,429 |
| Evan Roberts | Chief Operating Officer | $4,519,429 |
| David Linetsky | SVP, Network Solutions | $4,494,053 |
| Allison Hoffman | General Counsel | $2,967,637 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $8,273,308 |
| Balaji Gandhi | Chief Financial Officer | $5,913,217 |
| Evan Roberts | Chief Operating Officer | $4,499,693 |
| David Linetsky | SVP, Network Solutions | $4,474,215 |
| Randy Rasmussen | Former Chief Financial Officer | $3,332,602 |
| Allison Hoffman | General Counsel | $3,040,286 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $7,604,450 |
| Evan Roberts | Chief Operating Officer | $3,945,056 |
| Randy Rasmussen | Former Chief Financial Officer | $3,945,056 |
| David Linetsky | SVP, Network Solutions | $3,922,218 |
| Michael Davidoff | SVP, Payer Solutions | $2,843,184 |
| Allison Hoffman | General Counsel | $2,838,338 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $8,921,227 |
| Randy Rasmussen | Former Chief Financial Officer | $6,376,362 |
| David Linetsky | SVP, Life Sciences | $4,415,225 |
| Evan Roberts | Chief Operating Officer | $4,415,225 |
| Allison Hoffman | General Counsel | $3,053,528 |
| Thomas Altier | Former Chief Financial Officer | $243,750 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $6,405,296 |
| Allison Hoffman | General Counsel & Secretary | $3,916,970 |
| David Linetsky | SVP, Life Sciences | $3,078,354 |
| Evan Roberts | Chief Operating Officer | $3,078,354 |
| Thomas Altier | Former Chief Financial Officer | $1,203,353 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $10,474,444 |
| Evan Roberts | Chief Operating Officer | $3,622,209 |
| Thomas Altier | Former Chief Financial Officer | $2,525,119 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Chaim Indig | Chief Executive Officer | $510,249 |
| Thomas Altier | Former Chief Financial Officer | $380,124 |
| Evan Roberts | Chief Operating Officer | $380,124 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jon Kessler | Class I director | Appointed | 2026-02-23 |
| Michael Weintraub | Chair of the Board | Retired | 2026-02-23 |
| Edward L. Cahill | member of the Board of Directors | Retired | 2026-02-23 |
Key facts
CIK
1412408
CUSIP
71944F106
13F (30d)
155 filings
154 filers
Visit website
Investor relations